Worldwide Pharmaceutical Glass Tubing Industry to 2025 - Featuring Schott, Nipro Pharma & Corning Incorporated Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Pharmaceutical Glass Tubing Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The pharmaceutical glass tubing market was valued at USD 12.35 billion in 2019 and is projected to reach USD 20.75 billion by 2025, registering a CAGR of 5.5% over the forecast period, 2020 - 2025.

The manufacturing tools and fabrication techniques that are being used to manufacture pharmaceutical tubing have become extraordinarily complex. The complexity is primarily being driven by multiple applications in which the tubing is used. The most pharmaceutical application requires tubing that meets a set of specifications, and currently, the manufacturing methods are rapidly evolving to accommodate these broad categories of specifications.

According to the European Monitoring Centre for Drugs and Drug Addiction, the 2019 report, 517,381 syringes are distributed in Sweden.

Companies Mentioned

• Schott AG
• Nipro Pharma Corporation
• Corning Incorporated
• Nippon Electric Glass Co. Ltd.
• Accu-Glass LLC.
• Richland Glass Co. Inc.
• Cangzhou Four-star Glass Co. Ltd.
• LINUO Group
• DWK Life Sciences GmbH
• Aimer Products Limited
  

Key Market Trends

Application of Bottles is Witnessing Significant Growth

• Glass bottles are amongst the primary packaging material that has been widely used in the pharmaceutical industry. A considerable number of pharmaceutical formulations have been packaged using glass bottles, and they are usually the first choice of packaging materials.
• According to FEVE, the European Container Glass Federation, container glass production among FEVE members grew 217 thousand tonnes from 2018 levels and reached at 21,755 thousand tonnes and 78,662 million units, respectively in currently.
• The rapidly growing pharmaceutical industry across the various region of the world is boosting the growth of the market. The demand for pharmaceutical glass is majorly arising from stable economies, such as the United States and Canada. The increasing pharmaceutical production in these countries is further increasing the demand. According to IQVIA, pharmaceutical sales in the United States in 2019 was USD 491 billion. and global pharmaceutical sales were USD 1033 billion.

Asia-Pacific to Witness the Fastest Growth

• The demand for pharmaceutical glass tubing is majorly arising from prominent pharma nations in the Asia-Pacific region, such as India and China. The increasing pharmaceutical production in these countries is further increasing the demand.
• Further, manufacturers and suppliers are focusing on shifting their base to China and India, as a result of increasing opportunities offered by the pharmaceutical industry in these countries, especially in the generics sector.
• Also, China's National Health Commission forecasts that the total size of the Chinese healthcare industry is anticipated to reach CNY 16 trillion (USD 2.39 trillion) by 2030. According to the Chinese Center for Disease Control and Prevention, Institute for Health Metrics and Evaluation, China has reached a health tipping point, with chronic conditions replacing infectious diseases as the leading causes of early deaths in the nation of 1.4 billion people. Huge investments anticipated to control this scenario are expected to drive the demand from China.
• Moreover, India is the source of 60,000 generic medicine brands across 60 therapeutic categories and manufactures more than 500 different Active Pharmaceutical Ingredients (APIs). The Department of Pharmaceuticals is aiming to make the country a hub for end-to-end drug discovery under its Pharma Vision 2020.
• The companies are significantly expanding their manufacturing and production activities in the region. For instance, in Aug 2019, Germany-based Schott carried out a capacity expansion at its greenfield pharmaceutical glass tubing plant in Jinyun, Zhejiang, China. The new plant will enable the company to participate in the advancement of the Chinese pharmaceutical packaging industry. The company will invest EUR 60 million in the first phase to install a yearly capacity of up to 20,000 tons. The production is scheduled to initiated by the end of 2020.

Key Topics Covered:

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Growth of Pharmaceutical Industry in Emerging Economies

4.2.2 Commodity Value of Glass Increased with Recyclability

4.3 Market Restraints

4.3.1 Increased Relevance of Alternate Sources

4.4 Industry Value Chain Analysis

4.5 Porters 5 Force Analysis

4.5.1 Threat of New Entrants

4.5.2 Bargaining Power of Buyers/Consumers

4.5.3 Bargaining Power of Suppliers

4.5.4 Threat of Substitute Products

4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 Application

5.1.1 Bottles

5.1.2 Vials

5.1.3 Ampoules

5.1.4 Cartridges

5.1.5 Syringes

5.2 Geography

5.2.1 North America

5.2.2 Europe

5.2.3 Asia Pacific

5.2.4 Latin America

5.2.5 Middle East and Africa

6 COMPETITIVE LANDSCAPE

6.1 Key Vendor Profiles

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET

For more information about this report visit https://www.researchandmarkets.com/r/2fle7o